Home Healthcare Healthcare Services Chronic Pain Management Market

Chronic Pain Management Market Size, Share & Trends Analysis Report By Product Type (Drugs, Devices), By Pain Category (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Fibromyalgia, Migraine & Headache) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 02, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Chronic Pain Management Market, By Product Type 2025-2034 (USD MILLION/ Units)
    1. Drugs
      1. NSAIDs
      2. Opioids
      3. Antidepressants
      4. Anticonvulsants
      5. Muscle Relaxants
    2. Devices
      1. Neuromodulation Devices
      2. Ablation Devices
      3. Implantable Intrathecal Pumps
  2. Chronic Pain Management Market, By Pain Category 2025-2034 (USD MILLION/ Units)
    1. Neuropathic Pain
    2. Musculoskeletal Pain
    3. Cancer Pain
    4. Fibromyalgia
    5. Migraine & Headache
  3. Regional Chronic Pain Management Market
    1. North America
      1. North America Chronic Pain Management Market By Product Type 2025-2034 (USD MILLION/ Units)
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
      2. North America Chronic Pain Management Market By Pain Category 2025-2034 (USD MILLION/ Units)
        1. Neuropathic Pain
        2. Musculoskeletal Pain
        3. Cancer Pain
        4. Fibromyalgia
        5. Migraine & Headache
      3. U.S.
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      4. Canada
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
    2. Europe
      1. Europe Chronic Pain Management Market By Product Type 2025-2034 (USD MILLION/ Units)
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
      2. Europe Chronic Pain Management Market By Pain Category 2025-2034 (USD MILLION/ Units)
        1. Neuropathic Pain
        2. Musculoskeletal Pain
        3. Cancer Pain
        4. Fibromyalgia
        5. Migraine & Headache
      3. U.K.
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      4. Germany
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      5. France
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      6. Spain
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      7. Italy
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      8. Russia
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      9. Nordic
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      10. Benelux
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      11. Rest of Europe
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
    3. APAC
      1. APAC Chronic Pain Management Market By Product Type 2025-2034 (USD MILLION/ Units)
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
      2. APAC Chronic Pain Management Market By Pain Category 2025-2034 (USD MILLION/ Units)
        1. Neuropathic Pain
        2. Musculoskeletal Pain
        3. Cancer Pain
        4. Fibromyalgia
        5. Migraine & Headache
      3. China
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      4. Korea
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      5. Japan
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      6. India
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      7. Australia
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      8. Taiwan
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      9. South East Asia
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      10. Rest of Asia-Pacific
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
    4. Middle East and Africa
      1. Middle East and Africa Chronic Pain Management Market By Product Type 2025-2034 (USD MILLION/ Units)
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
      2. Middle East and Africa Chronic Pain Management Market By Pain Category 2025-2034 (USD MILLION/ Units)
        1. Neuropathic Pain
        2. Musculoskeletal Pain
        3. Cancer Pain
        4. Fibromyalgia
        5. Migraine & Headache
      3. UAE
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      4. Turkey
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      5. Saudi Arabia
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      6. South Africa
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      7. Egypt
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      8. Nigeria
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      9. Rest of MEA
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
    5. LATAM
      1. LATAM Chronic Pain Management Market By Product Type 2025-2034 (USD MILLION/ Units)
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
      2. LATAM Chronic Pain Management Market By Pain Category 2025-2034 (USD MILLION/ Units)
        1. Neuropathic Pain
        2. Musculoskeletal Pain
        3. Cancer Pain
        4. Fibromyalgia
        5. Migraine & Headache
      3. Brazil
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      4. Mexico
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      5. Argentina
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      6. Chile
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      7. Colombia
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
      8. Rest of LATAM
        1. Drugs
          1. NSAIDs
          2. Opioids
          3. Antidepressants
          4. Anticonvulsants
          5. Muscle Relaxants
        2. Devices
          1. Neuromodulation Devices
          2. Ablation Devices
          3. Implantable Intrathecal Pumps
        3. Neuropathic Pain
        4. Musculoskeletal Pain
        5. Cancer Pain
        6. Fibromyalgia
        7. Migraine & Headache
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.